On April 10, 2026, CMS released the FY 2027 Inpatient Prospective Payment System proposed rule, which includes a landmark proposal to create CJR-X — the Comprehensive Care for Joint Replacement Expanded model. If finalized, CJR-X would require nearly all IPPS-participating hospitals nationwide to accept bundled episode payments covering hip, knee, and ankle replacements performed in both inpatient and outpatient hospital settings, with episodes spanning 90 days post-discharge. The model is proposed to launch October 1, 2027, running through September 30, 2032.
Michigan MSK practices whose patients receive joint replacements at IPPS hospitals will operate within a mandatory bundled payment framework beginning October 2027, creating new pressure to reduce post-acute costs and demonstrate outcome quality. Synergy Health's partners must begin modeling episode cost exposure now, particularly for high-volume knee and hip cases, to negotiate shared-savings arrangements before target prices are set.
Alongside the CJR-X proposal, CMS's April 10 FY 2027 IPPS proposed rule puts forward significant updates to the existing TEAM (Transforming Episode Accountability Model), which became mandatory for 741 hospitals on January 1, 2026. The proposed changes would expand eligible spinal fusion episodes to include a broader range of procedure codes, better align attribution and quality metrics with other Medicare programs, and refine the target-price methodology. Comments on both TEAM and CJR-X updates are due June 9, 2026.
Spine surgery is a high-volume, high-revenue service line for Michigan MSK practices, and the proposed TEAM expansion would bring more spinal fusion cases under episode-based accountability, compressing margins if post-acute costs are not tightly managed. Practices affiliated with TEAM-participating hospitals face direct financial exposure beginning in the current performance year (2026).
On April 1, 2026, The Leapfrog Group announced a major expansion of its ASC Public Reporting Program, which will publicly rate the safety and quality of nearly 4,000 ambulatory surgery centers in the United States beginning in late July 2026. For the first time, patients, employers, and payers will be able to compare ASC performance across standardized safety metrics including never events, hand hygiene, safe surgery checklists, medication documentation, and health equity. The new Leapfrog ASC Survey 2.0 is now open with a submission deadline of June 30, 2026.
Public ratings create immediate reputational and competitive risk for Michigan orthopedic ASCs: a low score published in late July 2026 will be visible to self-insured employers and insurers — including BCBS of Michigan — during fall 2026 network negotiations. Completing the survey and achieving strong ratings before the deadline is a direct patient-volume protection measure.
The CY 2026 CMS OPPS/ASC Final Rule, effective January 1, 2026, added 271 musculoskeletal procedure codes to the ASC Covered Procedures List (CPL) as a result of CMS phasing out the Inpatient-Only (IPO) list. An additional 289 codes were added through standard criteria changes. The rule also increased Medicare ASC payment rates by 2.6% (based on a 3.3% market basket increase minus a 0.7% productivity adjustment). In total, 285 predominantly MSK procedures were removed from the IPO list for CY2026.
This is the single largest expansion of ASC-eligible orthopedic procedures in Medicare history, creating immediate revenue capture opportunities for Michigan MSK ASCs that have not yet added the newly approved procedure codes to their billing schedules. Practices that have not updated their charge masters since January 1 may be leaving reimbursable revenue on the table today.
On April 8, 2026, Covenant HealthCare broke ground on a new $25 million, 25,700-square-foot orthopedic and musculoskeletal care facility in Saginaw Township, Michigan. The building will consolidate Covenant's outpatient orthopedic services at its Mackinaw campus and will feature 44 exam rooms, four X-ray suites, casting and procedure rooms, orthotics and prosthetics services, and Covenant OrthoExpress — described as one of the only orthopedic-focused urgent care centers in mid-Michigan. The facility is expected to open in summer 2027.
This investment significantly increases Covenant's MSK care capacity in the mid-Michigan market and introduces a walk-in orthopedic urgent care model that may divert acute musculoskeletal cases away from independent practices. Michigan orthopedic groups should evaluate their own urgent care access strategy before Covenant OrthoExpress opens in summer 2027.
Becker's ASC reports that 15 orthopedic clinic locations and ambulatory surgery centers opened in Q1 2026, spanning independent surgeon groups, major health systems, and children's hospitals. The openings reflect a broad national trend of orthopedic groups accelerating expansion into the ASC and outpatient clinic space in direct response to CMS removing nearly 300 musculoskeletal procedures from the Inpatient-Only list. Notable openings include facilities in Michigan (Covenant HealthCare, Saginaw), New York, Indiana, Texas, and Iowa.
The rapid pace of new orthopedic facility openings — including in Michigan — signals intensifying competition for MSK market share across the Midwest. Practices that delay ASC expansion or outpatient site development risk ceding volume to better-positioned competitors during a period when CMS policy is actively rewarding outpatient delivery.
Becker's ASC reports that global healthcare private equity deal value reached an estimated $191 billion in 2025, surpassing the 2021 peak, with 445 buyouts recorded — the second-highest count ever. In orthopedics specifically, the strategy has shifted from building standalone ASC platforms toward integrated physician-MSO models that pair management infrastructure with ASC assets. Notable 2026 entrants include Evolve Orthopedic Partners (backed by Zenyth Partners, anchored by OrthoNY) and physician-led platforms that combine clinic, ASC, imaging, and administrative support under single ownership structures.
The PE-backed integrated MSO model is rapidly becoming the dominant competitive structure in orthopedics nationally, and Michigan practices that remain independent without a clear governance strategy may face increasing difficulty competing for talent, contracts, and capital. Understanding current MSO valuation multiples and deal structures is essential for Michigan orthopedic leaders making partnership decisions in 2026.
A 2026 narrative review published in Frontiers in Bioengineering and Biotechnology examines how artificial intelligence and robotic systems are transforming orthopedic surgical precision and personalization. The paper identifies three converging clinical domains: machine learning for perioperative risk prediction and bone segmentation (with AI-enhanced MRI cutting knee scan time from 11 to 5 minutes); robotic surgical platforms (including MAKO, ROSA, and NAVIO); and large language models for surgical workflow decision support. The review also covers smart implants enabling in-vivo post-surgical monitoring and digital twin technology for patient-specific simulation.
AI-powered imaging and robotic-assisted surgery are transitioning from differentiators to expected capabilities in high-volume orthopedic practices, and Michigan MSK leaders who have not yet developed a formal technology roadmap risk falling behind in both patient outcomes and payer contract positioning as quality metrics increasingly capture technology-mediated results.